Nanotechnology, the
manipulation of matter on atomic, molecular,
and supramolecular scales, has become the most appealing strategy
for biomedical applications and is of great interest as an approach
to preventing microbial risks. In this study, we utilize the antimicrobial
performance and the drug-loading ability of novel nanoparticles based
on silicon oxide and strontium-substituted hydroxyapatite to develop
nanocomposite antimicrobial films based on a poly(
l
-lactic
acid) (PLLA) polymer. We also demonstrate that nanoimprint lithography
(NIL), a process adaptable to industrial application, is a feasible
fabrication technique to modify the surface of PLLA, to alter its
physical properties, and to utilize it for antibacterial applications.
Various nanocomposite PLLA films with nanosized (black silicon) and
three-dimensional (hierarchical) hybrid domains were fabricated by
thermal NIL, and their bactericidal activity against
Escherichia coli
and
Staphylococcus
aureus
was assessed. Our findings demonstrate that
besides hydrophobicity the nanoparticle antibiotic delivery and the
surface roughness are essential factors that affect the biofilm formation.